secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0001437749-25-001928
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Q4 revenue $36.9M, EPS $0.28; CTO Louvion resigns
-----------------------------------------------------

- Q4 revenue $36.9M vs $38.0M YoY; diluted EPS $0.28 vs $0.36.
- Net indebtedness $58.5M; total recurring contract value $133.2M at Dec 31, 2024.
- Returned $10.1M to shareholders: $7.3M in stock repurchases (393k shares) plus $0.12/share dividend.
- Chief Product Technology Officer Chrisophe Louvion resigned effective Jan 27, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/0001437749-25-001928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774925001928/nrc20250124_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-001928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer